16 results
Treatment Algorithm for First Time DVT
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke, MD.

#DVT
Treatment Algorithm ... #DVT #Treatment ... #Algorithm #management ... #hematology #VTE ... #thrombosis #venous
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... Pulmonary #Embolism #Treatment ... #Algorithm #management ... #hematology #VTE ... #thrombosis #venous
Stroke - Differential Diagnosis Algorithm and Management
Hemorrhagic:
 • Intracerebral: HTN, Cerebral Amyloid Angiopathy, Trauma, Bleeding Diathesis,
Differential Diagnosis Algorithm ... Tumor, Cerebral Venous ... Thrombosis, Hemorrhagic ... #management #neurology ... #treatment
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... mass index; VTE = venous ... Malignancy #Cancer #Algorithm ... #Oncology
Approach to the Rash in a an oncology patient - MINT-C Mnemonic
M - Malignancy: Leukemia cutis,
the Rash in a an oncology ... Dermatoses: Sweet Syndrome ... , Pyoderma Gangrenosum ... , NEH T - Treatment ... MINTC #Mnemonic #dermatology
Causes of Seizures - Differential Diagnosis Algorithm
Unprovoked - Epilepsy:
 • Focal: Simple, Complex
 • Generalized: Absence,
Differential Diagnosis Algorithm ... ICH, Cerebral venous ... thrombosis, Congenital ... vasoconstriction syndrome ... #Causes #neurology
2019 EULAR recommendations for thrombosis in (Antiphospholipid Syndrome) APS
Venous Thrombosis - Arterial Thrombosis
INR Target
Duration
Recurrence

Dr. Laurent ARNAUD
Antiphospholipid Syndrome ... ) APS Venous Thrombosis ... Antiphospholipid #Syndrome ... #rheumatology #hematology ... #treatment
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... algorithm for symptomatic ... thrombosis in cancer ... Anticoagulation #Management #Hematology ... #Oncology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
of Therapy for Venous ... • Superficial Venous ... syndrome - ... management #DVT #hematology ... #length #treatment
Paraproteinemias

Entities That Can Feature A Monoclonal Protein/M Component:
• MM
• WM
• MGUS
• MGCS
• MGRS
• Splenic Marginal Zone
dermatosis • Pyoderma gangrenosum ... et diutinum Neurologic ... Organomegaly+↑RBC/plt+, ↑thrombosis ... Hyperviscosity (Thrombosis ... Differential #Diagnosis #Oncology